- Tytuł:
- Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration.
- Autorzy:
- Źródło:
- Multiple Sclerosis & Related Disorders; Apr2022, Vol. 60, pN.PAG-N.PAG, 1p
Czasopismo naukowe